Waters Corporation
Waters Corporation Reports Strong First Quarter 2025 Financial Results
Summary
Waters Corporation announced its first quarter 2025 financial results, showing sales of $662 million, a 4% increase as reported and 7% in constant currency. GAAP earnings per share (EPS) were $2.03, and non-GAAP EPS was $2.25. The company raised its full-year 2025 constant currency sales growth guidance to +5.0% to +7.0% and non-GAAP EPS guidance to the range of $12.75 to $13.05. These results reflect strong instrument growth, particularly in the Pharma and Industrial end markets.
Profitelligence Alerts
Get alerts for WAT
Be first to know when Waters Corporation files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About Waters Corporation
Waters Corporation is a leading entity in the field of analytical instruments and software. It primarily focuses on providing laboratory solutions for a variety of sectors, including pharmaceuticals, healthcare, food and beverage, and chemical analysis. The company's offerings include high-performance liquid chromatography, mass spectrometry systems, and various supporting technologies used for advanced research in life sciences. Waters Corporation is pivotal in enhancing laboratory productivity, offering cutting-edge research tools that assist in drug development, quality control, and environmental testing. Operating globally, it serves a wide array of clients, including academic institutions, government agencies, and private industry players. With its commitment to innovation and precision, Waters Corporation plays a crucial role in advancing scientific and technological progress in multiple critical industries worldwide.
Official SEC Documents
Advertisement